Walther Frans J, Waring Alan J, Hernandez-Juviel Jose M, Gordon Larry M, Schwan Adrian L, Jung Chun-Ling, Chang Yusuo, Wang Zhengdong, Notter Robert H
Los Angeles Biomedical Research Institute, Harbor-University of California at Los Angeles Medical Center, Torrance, California, United States of America.
PLoS One. 2007 Oct 17;2(10):e1039. doi: 10.1371/journal.pone.0001039.
This study examines the surface activity and resistance to phospholipase degradation of a fully-synthetic lung surfactant containing a novel diether phosphonolipid (DEPN-8) plus a 34 amino acid peptide (Mini-B) related to native surfactant protein (SP)-B. Activity studies used adsorption, pulsating bubble, and captive bubble methods to assess a range of surface behaviors, supplemented by molecular studies using Fourier transform infrared (FTIR) spectroscopy, circular dichroism (CD), and plasmon resonance. Calf lung surfactant extract (CLSE) was used as a positive control.
DEPN-8+1.5% (by wt.) Mini-B was fully resistant to degradation by phospholipase A(2) (PLA(2)) in vitro, while CLSE was severely degraded by this enzyme. Mini-B interacted with DEPN-8 at the molecular level based on FTIR spectroscopy, and had significant plasmon resonance binding affinity for DEPN-8. DEPN-8+1.5% Mini-B had greatly increased adsorption compared to DEPN-8 alone, but did not fully equal the very high adsorption of CLSE. In pulsating bubble studies at a low phospholipid concentration of 0.5 mg/ml, DEPN-8+1.5% Mini-B and CLSE both reached minimum surface tensions <1 mN/m after 10 min of cycling. DEPN-8 (2.5 mg/ml)+1.5% Mini-B and CLSE (2.5 mg/ml) also reached minimum surface tensions <1 mN/m at 10 min of pulsation in the presence of serum albumin (3 mg/ml) on the pulsating bubble. In captive bubble studies, DEPN-8+1.5% Mini-B and CLSE both generated minimum surface tensions <1 mN/m on 10 successive cycles of compression/expansion at quasi-static and dynamic rates.
These results show that DEPN-8 and 1.5% Mini-B form an interactive binary molecular mixture with very high surface activity and the ability to resist degradation by phospholipases in inflammatory lung injury. These characteristics are promising for the development of related fully-synthetic lipid/peptide exogenous surfactants for treating diseases of surfactant deficiency or dysfunction.
本研究考察了一种全合成肺表面活性剂的表面活性及对磷脂酶降解的抗性,该表面活性剂含有一种新型二醚磷脂(DEPN - 8)以及一种与天然表面活性蛋白(SP)-B相关的34个氨基酸的肽(Mini - B)。活性研究采用吸附法、脉动气泡法和俘获气泡法来评估一系列表面行为,并辅以使用傅里叶变换红外(FTIR)光谱、圆二色性(CD)和等离子体共振的分子研究。小牛肺表面活性剂提取物(CLSE)用作阳性对照。
DEPN - 8 + 1.5%(重量)Mini - B在体外对磷脂酶A₂(PLA₂)的降解具有完全抗性,而CLSE被该酶严重降解。基于FTIR光谱,Mini - B在分子水平上与DEPN - 8相互作用,并且对DEPN - 8具有显著的等离子体共振结合亲和力。与单独的DEPN - 8相比,DEPN - 8 + 1.5% Mini - B的吸附大大增加,但并未完全达到CLSE的非常高的吸附水平。在低磷脂浓度0.5 mg/ml的脉动气泡研究中,经过10分钟循环后,DEPN - 8 + 1.5% Mini - B和CLSE均达到最低表面张力<1 mN/m。在存在血清白蛋白(3 mg/ml)的情况下,DEPN - 8(2.5 mg/ml)+ 1.5% Mini - B和CLSE(2.5 mg/ml)在脉动气泡中脉动10分钟时也达到最低表面张力<1 mN/m。在俘获气泡研究中,DEPN - 8 + 1.5% Mini - B和CLSE在准静态和动态速率下连续10个压缩/膨胀循环中均产生最低表面张力<1 mN/m。
这些结果表明,DEPN - 8和1.5% Mini - B形成了一种具有非常高表面活性且能够抵抗炎症性肺损伤中磷脂酶降解的交互式二元分子混合物。这些特性对于开发用于治疗表面活性剂缺乏或功能障碍疾病的相关全合成脂质/肽外源性表面活性剂很有前景。